Pre-transplant cytoreductive therapy can improve overall survival of patients with MDS-AML but not MDS-EB2 receiving HLA-matched sibling donor peripheral blood stem cell transplantation.
Wang Q, Zhao X, Liu Z, Zhao X, Zhang G, Yao J, Zheng X, Zhang L, Shen Y, He Y, Huang Y, Zhang R, Wei J, Ma Q, Pang A, Yang D, Jiang E, Feng S, Zhang Z, Zhai W, Han M.
Wang Q, et al. Among authors: yao j.
Am J Cancer Res. 2020 Apr 1;10(4):1218-1228. eCollection 2020.
Am J Cancer Res. 2020.
PMID: 32368397
Free PMC article.